ID22957A - Senyawa dan penggunaannya - Google Patents

Senyawa dan penggunaannya

Info

Publication number
ID22957A
ID22957A IDP990201D ID990201D ID22957A ID 22957 A ID22957 A ID 22957A ID P990201 D IDP990201 D ID P990201D ID 990201 D ID990201 D ID 990201D ID 22957 A ID22957 A ID 22957A
Authority
ID
Indonesia
Prior art keywords
compound
Prior art date
Application number
IDP990201D
Other languages
English (en)
Indonesian (id)
Inventor
Lorraine Mary Edmeades
Nigel Arthur Griffith-Skinner
Derek Anthony Hill
Graham Thronton Hill
Terence Williampackham
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10833464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID22957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ID22957A publication Critical patent/ID22957A/id

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90Plate chromatography, e.g. thin layer or paper chromatography
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555Hetero-N
    • Y10T436/147777Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IDP990201D 1998-06-10 1999-03-10 Senyawa dan penggunaannya ID22957A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9812413.4A GB9812413D0 (en) 1998-06-10 1998-06-10 Compound and its use

Publications (1)

Publication Number Publication Date
ID22957A true ID22957A (id) 1999-12-23

Family

ID=10833464

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990201D ID22957A (id) 1998-06-10 1999-03-10 Senyawa dan penggunaannya

Country Status (31)

Country Link
US (1) US6333198B1 (fr)
EP (2) EP0963980B1 (fr)
JP (1) JP2989189B1 (fr)
KR (1) KR100322354B1 (fr)
CN (2) CN1238454A (fr)
AP (3) AP0102286A0 (fr)
AR (1) AR014074A1 (fr)
AT (1) ATE218552T1 (fr)
AU (1) AU2031999A (fr)
BR (1) BR9900984A (fr)
CA (1) CA2265194C (fr)
DE (1) DE69901656T2 (fr)
DK (1) DK0963980T3 (fr)
EA (1) EA000666B1 (fr)
ES (1) ES2178342T3 (fr)
GB (1) GB9812413D0 (fr)
HR (1) HRP990074A2 (fr)
HU (1) HUP9900592A3 (fr)
ID (1) ID22957A (fr)
MA (1) MA24777A1 (fr)
NO (2) NO991151L (fr)
NZ (1) NZ334590A (fr)
PE (1) PE20000332A1 (fr)
PL (1) PL331870A1 (fr)
PT (1) PT963980E (fr)
SG (1) SG85628A1 (fr)
SI (1) SI0963980T1 (fr)
TR (1) TR199900520A3 (fr)
UY (1) UY25946A1 (fr)
YU (1) YU12399A (fr)
ZA (1) ZA991951B (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055177A1 (en) * 1999-03-10 2002-05-09 Glaxo Wellcome Inc. Compound and its use
US6639072B1 (en) 2000-01-03 2003-10-28 Rpg Life Sciences Limited Process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
GB2371862B (en) * 2000-12-29 2004-07-14 Bioorg Bv Reference standards for determining the purity or stability of amlodipine maleate and processes therefor
BR0116553A (pt) 2000-12-29 2004-02-03 Pfizer Ltd Composto, composição farmacêutica para tratamento de angina ou hipertensão, processo, processo para tratamento ou prevenção de angina ou hipertensão, composição de ingredientes farmaceuticamente ativos, composição farmacêutica para tratamento ou prevenção de angina ou hipertensão e processo para tratar ou prevenir angina ou hipertensão
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
BR0116557A (pt) 2000-12-29 2003-10-28 Pfizer Ltd Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina
EP1309556B1 (fr) 2000-12-29 2004-11-24 Pfizer Limited Fumarate d'amlodipine
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
EP1309554A1 (fr) 2000-12-29 2003-05-14 Synthon Licensing, Ltd. Derive d'amide d'amlodipine
DE60116514T2 (de) 2000-12-29 2006-08-17 Pfizer Ltd., Sandwich Amlodipinhemimaleat
DE10134980C2 (de) * 2001-07-17 2003-05-28 Helm Ag Verfahren zur Herstellung von Lamotrigin
CA2366521C (fr) 2001-12-24 2007-03-06 Brantford Chemicals Inc. Un procede nouveau et efficace de preparation de lamotrigine et d'autres 3,5-diamino-1,2,4-triazines substituees en position 6
CA2479668A1 (fr) * 2002-03-20 2003-10-02 Teva Pharmaceutical Industries Ltd. Formes cristallines d'hemifumarate de quetiapine
HU225667B1 (en) 2002-09-20 2007-05-29 Richter Gedeon Nyrt Method for producing high-purity 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
ES2209639B1 (es) 2002-10-31 2005-08-01 Vita Cientifica, S.L. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y obtencion de su intermedio.
GB2395483A (en) * 2003-07-03 2004-05-26 Jubilant Organosys Ltd Crystalline lamotrigine and its monohydrate
EP1562912A2 (fr) 2003-08-28 2005-08-17 Teva Pharmaceutical Industries Limited Procede de preparation de sels calciques de rosuvastatine
EP1601658A1 (fr) * 2003-11-24 2005-12-07 Teva Pharmaceutical Industries Limited Sels d'ammonium cristallins de la rosuvastatine
ATE507209T1 (de) * 2003-12-02 2011-05-15 Teva Pharma Referenzstandard zur charakterisierung von rosuvastatin
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
EP1709002A2 (fr) * 2004-01-30 2006-10-11 Teva Pharmaceutical Industries Ltd. Montelukast de sodium polymorphe
US20050187243A1 (en) * 2004-01-30 2005-08-25 Valerie Niddam-Hildesheim Montelukast free acid polymorphs
MD2823G2 (ro) * 2004-02-12 2006-05-31 Институт Химии Академии Наук Молдовы Procedeu de determinare cantitativă a sclareolului în extractele, obţinute din salvia de muscat
DE602005015174D1 (de) * 2004-04-21 2009-08-13 Teva Pharma Verfahren zur herstellung von montelukast-natrium
JP2007532585A (ja) 2004-04-26 2007-11-15 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ミコフェノール酸及びそのエステル誘導体の調製方法
WO2005105769A2 (fr) * 2004-04-27 2005-11-10 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg - Impureté du mofétilmycophénolate
US7439399B2 (en) * 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
US7317127B2 (en) * 2004-06-28 2008-01-08 Teva Pharmaceutical Fine Chemicals S.R.L Process for the optical resolution and recycling of tomoxetine
EP1673351A1 (fr) * 2004-07-13 2006-06-28 Teva Pharmaceutical Industries Ltd. Procede pour la preparation de rosuvastatin comprenant une etape d'oxydation mediee par tempo
ES2340184T3 (es) * 2004-07-20 2010-05-31 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Micofenolato sodico cristalino.
WO2006020348A2 (fr) * 2004-07-22 2006-02-23 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphes du chlorhydrate d'atomoxetine
CA2578750A1 (fr) * 2004-09-04 2006-03-16 Teva Pharmaceutical Industries, Ltd. Support conditionne de cellules progenitrices autologues ou allogenes pour traitement de l'angiogenese
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
TWI321132B (en) * 2004-09-28 2010-03-01 Teva Pharma Process for preparing forms of atorvastatin calcium substantially free of impurities
JP2007514777A (ja) * 2004-10-19 2007-06-07 テバ ファーマシューティカル インダストリーズ リミティド テガセロッドマレエートの精製
US7678551B2 (en) * 2004-10-25 2010-03-16 Seradyn, Inc. Immunoassays for lamotrigine
JP2007523213A (ja) * 2004-12-23 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法
ES2334579T3 (es) * 2005-01-11 2010-03-12 Teva Pharmaceutical Fine Chemicals S.R.L. Procedimiento para la preparacion del clorhidrato de 1-amino-3,5-dimetil-adamantano.
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
CA2591439C (fr) * 2005-02-22 2013-03-26 Teva Pharmaceutical Industries Ltd. Rosuvastatine, sels de rosuvastatine exempts de son alkylether, procede d'elaboration correspondant
US7291614B2 (en) * 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
WO2006099459A1 (fr) * 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Procede de preparation du compose optiquement actif (s)-(+)-n,n-dimethyl-3-(1-naphtalenyloxy)-3-(2-thienyl)propanamine
US7569729B2 (en) * 2005-04-05 2009-08-04 Teva Pharmaceutical Fine Chemicals S.R.L. Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
WO2006108151A1 (fr) * 2005-04-06 2006-10-12 Teva Pharmaceutical Industries Ltd. Formes cristallines de pregabaline
EP1768950A2 (fr) * 2005-04-11 2007-04-04 Teva Pharmaceutical Industries Ltd. Procede de fabrication de (s)-pregabaline
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
WO2006113425A1 (fr) * 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Processus de preparation de fumarate de quetiapine
US20080281111A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
MX2007000525A (es) * 2005-05-10 2007-03-28 Teva Pharma Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella.
ATE486841T1 (de) * 2005-05-10 2010-11-15 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
EP1879852A1 (fr) * 2005-05-10 2008-01-23 Teva Pharmaceutical Industries Ltd Pregabaline exempte de lactame et son procede de preparation
KR20070118305A (ko) * 2005-05-10 2007-12-14 테바 파마슈티컬 인더스트리즈 리미티드 3-카르바모일메틸-5-메틸 헥산산의 광학 분할
CN101180261A (zh) 2005-05-23 2008-05-14 特瓦制药工业有限公司 用于制备盐酸西那卡塞晶型ⅰ的方法
US20070032660A1 (en) * 2005-06-27 2007-02-08 Alessandro Pontiroli Purification process for Anastrozole intermediate
BRPI0611116A2 (pt) * 2005-06-27 2010-08-10 Sicor Inc uma impureza de intermediário de anastrozol e seus usos
CA2608369A1 (fr) * 2005-07-05 2007-01-11 Teva Pharmaceutical Industries Ltd. Purification du montelukast
WO2007022488A2 (fr) * 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Intermediaire de rosuvastatine sous forme cristalline
KR20080034205A (ko) * 2005-09-19 2008-04-18 테바 파마슈티컬 인더스트리즈 리미티드 (s)-프레가발린의 신규한 합성을 위한 주요 중간체인 키랄3-카르바모일메틸-5-메틸 헥산산
US20070197529A1 (en) * 2005-12-01 2007-08-23 Viviana Braude Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
WO2007067581A1 (fr) * 2005-12-05 2007-06-14 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol)thiophene, une impurete du duloxetine chlorhydrate
WO2007069264A2 (fr) * 2005-12-15 2007-06-21 Alembic Limited Nouveaux composes
US20070197630A1 (en) * 2005-12-27 2007-08-23 Valeriano Merli Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
US20080033054A1 (en) * 2006-03-27 2008-02-07 Valeriano Merli Process for preparing memantine hydrochloride substantially free of impurities
US20080146675A1 (en) * 2006-04-05 2008-06-19 Eugenio Castelli Stable Atomoxetine Hydrochloride, a process for the preparation thereof, and an analytical control of its stability
GB0609835D0 (en) * 2006-05-18 2006-06-28 Pliva Istrazivanje I Razvoj D Impurities of a pharmaceutical product
WO2007139933A2 (fr) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Procédés pour la préparation d'acide r-(+)-3-(carbamoyl méthyl)-5-méthylhexanoïque et de sels de celui-ci
KR20080036060A (ko) * 2006-05-31 2008-04-24 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법
EP1912931A2 (fr) * 2006-05-31 2008-04-23 Teva Pharmaceutical Industries Ltd. Préparation de (s)-prégabaline nitrile
WO2008002665A1 (fr) * 2006-06-29 2008-01-03 Teva Pharmaceutical Industries Ltd. Régulation de la production de métabolites acides
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
CN101506178A (zh) * 2006-08-14 2009-08-12 隆沙有限公司 制备拉莫三嗪的方法
EP2139845A1 (fr) * 2007-02-26 2010-01-06 Teva Pharmaceutical Industries Ltd. Intermédiaires et procédés pour la synthèse de ramelteon
TW200846308A (en) * 2007-03-22 2008-12-01 Teva Pharma Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
US20080254520A1 (en) * 2007-04-11 2008-10-16 Eva Gulyas Method for reducing impurity level in mycophenolic acid fermentation
US8084630B2 (en) * 2007-05-31 2011-12-27 Teva Pharmaceutical Industries Ltd. Process for the synthesis of ramelteon and its intermediates
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
PL2508523T5 (pl) * 2007-10-23 2020-08-10 Teva Pharmaceutical Industries Ltd. Odmiany polimorficzne dasatynibu i sposób ich wytwarzania
WO2009056993A2 (fr) * 2007-11-01 2009-05-07 Teva Pharmaceutical Industries Ltd. Procédé de synthèse de rameltéon et intermédiaires de ce dernier
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine
CA2717580A1 (fr) * 2008-03-06 2009-12-17 Teva Pharmaceutical Industries Ltd. Procedes de preparation de la o-desmethylvenlafaxine, exempte de ses impuretes dimeres
WO2009158343A1 (fr) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Synthèse enzymatique stéréosélective de l’ester (s) ou (r)-isobutylglutarique
WO2010045565A1 (fr) * 2008-10-16 2010-04-22 Teva Pharmaceutical Industries Ltd. Procédé de synthèse du ramelteon et de ses intermédiaires
EP2539313A2 (fr) * 2010-03-29 2013-01-02 Pliva Hrvatska D.O.O. Formes cristallines du fumarate de o-desméthylvenlafaxine
WO2012034065A1 (fr) 2010-09-09 2012-03-15 Teva Pharmaceutical Industries Ltd. Intermédiaires d'aliskirène et procédé destiné à analyser la pureté de l'aliskirène
CN102766104A (zh) * 2012-08-20 2012-11-07 三金集团湖南三金制药有限责任公司 一种治疗双向情感障碍及癫痫病药物拉莫三嗪的合成方法
US10189859B2 (en) 2013-12-21 2019-01-29 Nektar Therapeutics Derivatives of 6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine
CN110467560A (zh) 2018-05-09 2019-11-19 深圳微芯生物科技股份有限公司 一种苯基氨基丙酸钠衍生物、其制备方法和应用
KR102270026B1 (ko) * 2020-01-31 2021-06-28 현대약품 주식회사 (3s)-3-(4-(3-(1,4-다이옥사스파이로[4,5]데스-7-엔-8-일)벤질옥시)페닐)헥스-4-이노익산의 품질 평가 방법
CN113156009B (zh) * 2021-04-20 2023-12-22 三金集团湖南三金制药有限责任公司 高效液相色谱分析拉莫三嗪的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625170A (en) 1979-06-01 1981-03-10 Wellcome Found Triazine derivative
HU182086B (en) 1979-06-01 1983-12-28 Wellcome Found Process for preparing new 1,2,4-triazine derivatives
GB8613183D0 (en) 1986-05-30 1986-07-02 Wellcome Found Triazine salt
ES2177672T3 (es) * 1994-12-30 2002-12-16 Wellcome Found Procedimiento para preparacion de lamotrigina.
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation

Also Published As

Publication number Publication date
EP0963980B1 (fr) 2002-06-05
EP1170588A1 (fr) 2002-01-09
EP0963980A2 (fr) 1999-12-15
JP2989189B1 (ja) 1999-12-13
NO20032753L (no) 1999-12-13
TR199900520A2 (en) 2000-01-21
US6333198B1 (en) 2001-12-25
HUP9900592A3 (en) 2002-04-29
NO991151D0 (no) 1999-03-10
CN1238454A (zh) 1999-12-15
AU2031999A (en) 2000-01-06
NO991151L (no) 1999-12-13
PL331870A1 (en) 1999-12-20
AR014074A1 (es) 2001-01-31
CA2265194C (fr) 2000-10-10
AP9901481A0 (en) 1999-03-31
UY25946A1 (es) 2000-12-29
MA24777A1 (fr) 1999-10-01
DK0963980T3 (da) 2002-09-16
AP0102286A0 (en) 2000-09-10
SI0963980T1 (en) 2002-12-31
SG85628A1 (en) 2002-01-15
EP0963980A3 (fr) 2000-05-31
KR20000005611A (ko) 2000-01-25
EA199900159A1 (ru) 1999-12-29
DE69901656D1 (de) 2002-07-11
NO20032753D0 (no) 2003-06-17
CN1306210A (zh) 2001-08-01
ZA991951B (en) 1999-08-16
AP2001002286A0 (en) 2001-12-31
HU9900592D0 (en) 1999-04-28
ATE218552T1 (de) 2002-06-15
JP2000009714A (ja) 2000-01-14
TR199900520A3 (tr) 2000-01-21
BR9900984A (pt) 2000-05-02
NZ334590A (en) 2000-07-28
KR100322354B1 (ko) 2002-02-07
EA000666B1 (ru) 2000-02-28
ES2178342T3 (es) 2002-12-16
HRP990074A2 (en) 2000-10-31
YU12399A (sh) 2002-08-12
HUP9900592A2 (hu) 2000-04-28
DE69901656T2 (de) 2003-01-30
PE20000332A1 (es) 2000-04-10
GB9812413D0 (en) 1998-08-05
PT963980E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
ID22957A (id) Senyawa dan penggunaannya
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
ID24196A (id) Komposisi dan penggunaan
ID28990A (id) Herbisida-herbisida dengan urea aminofenilsulfonil asilasi
ID19422A (id) Piridina dan bifenil tersubstitusi
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID26848A (id) Koupling untuk gigi-gigi eksapator dan sejenisnya
ID23076A (id) Popok sekali pakai
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
NO20001830D0 (no) Ny kombinasjon
NO20005503L (no) Ny anvendelse
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID29943A (id) Senyawa dds dan metode pengukurannya
ID26599A (id) Turunan triazola dan imidazola
ID22956A (id) Sintesa disulfida dan polisulfida organik
ID27480A (id) Pembungkusan berstruktur dan elemennya
ID23083A (id) Popok sekali pakai
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID26156A (id) Benzotiadiazol dan turunan-turunan